Doctors accusing a drug company of violating a consumer harassment law by faxing invitations to a free dinner seminar on a sexual disorder—while the company was seeking approval of a drug to treat it—have had their case resurrected.
The doctors claim Boehringer Ingelheim Pharmaceuticals violated the federal Telephone Consumer Protection Act of 1991 (TCPA) by sending unsolicited faxes for a dinner talk on female sexual dysfunction and hypoactive sexual desire disorder.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
